2D-LC
IndustriesPharma & Biopharma
ManufacturerSignificance of the Topic
Advances in biologics production and extracellular vesicle research demand robust analytical workflows capable of extracting multiple high-value products from complex cell culture media. Two-dimensional liquid chromatography (2D-LC) offers a promising solution by coupling affinity capture of monoclonal antibodies with downstream hydrophobic interaction chromatography to isolate both IgG and exosomes in a single integrated process.
Study Objectives and Overview
This work aimed to develop and validate a 2D-LC method that:
- Recovers therapeutic IgG from CHO cell culture supernatants via Protein A affinity on capillary-channeled polymer fibers (C-CP).
- Recovers and purifies exosomes from the Protein A effluent using a second dimension hydrophobic interaction chromatography (HIC).
- Demonstrates quantitative performance, high purity, and feasibility for process analytical technology (PAT) integration.
Methodology and Instrumentation
The process employed two sequential separation dimensions:
- Dimension 1 (1D): Protein A affinity chromatography on polypropylene C-CP fiber columns, eluted by pH gradient to capture IgG selectively.
- Dimension 2 (2D): Hydrophobic interaction chromatography on polyester C-CP fibers with an inverse salt/organic modifier gradient to retain and elute exosomes.
Instrumentation included:
- Two HPLC pumps delivering mobile phases for each dimension.
- A modular 2D switch for timed transfer of 1D effluent to 2D loop.
- UV detectors for IgG quantitation in 1D and exosome quantitation in 2D.
- Custom C-CP fiber columns (PP for Protein A, PET for HIC) mounted in capillaries.
Results and Discussion
IgG Performance:
- Recovery linear over 1–8 µg injections (R² = 0.99).
- Yield exceeded 95% with RSD <5%.
- Purity confirmed by SDS-PAGE, comparable to commercial columns.
Exosome Performance:
- Average particle diameter 83 ± 23 nm by nano-flow cytometry.
- Immunolabeling showed ~66% tetraspanin‐positive vesicles (CD9, CD63, CD81).
- Membrane staining indicated ~93% vesicle integrity.
- Recovery of ~1.8×1011 particles/mL with <7% RSD.
- Host cell protein content reduced by >99% (3 mg/mL to 3 µg/mL).
- Purity >5×1010 particles/µg protein, meeting NIH guidelines.
Benefits and Practical Applications
This approach enables concurrent capture of therapeutic antibodies and high-purity exosomes from the same bioreactor harvest, delivering:
- Resource recovery by valorizing the Protein A effluent.
- Enhanced PAT capabilities for real-time monitoring of cell culture health and productivity.
- Cost savings using inexpensive C-CP fiber columns (<$5 each) with in-house chemistry modification.
Future Trends and Potential Applications
Potential extensions include:
- Analytical scale C-CP columns for high-throughput screening.
- Isotopic labeling (e.g., Yb) of exosomes for ICP-MS quantitation.
- Functional assays of HIC-isolated exosomes in cellular uptake studies.
- Anion exchange chromatography using polymer fiber modifications.
- Adaptations for liposome and adeno-associated virus (AAV) separations.
Conclusion
The developed 2D-LC workflow successfully integrates Protein A affinity and HIC on capillary-channeled polymer fiber columns to isolate and quantify both therapeutic IgG and exosomes from CHO supernatant. The method achieves high yield, purity, and reproducibility using cost-effective materials, offering a scalable platform for downstream processing and advanced bioprocess analytics.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.